John M Davis

Summary

Affiliation: University of Illinois at Chicago
Country: USA

Publications

  1. ncbi The choice of drugs for schizophrenia
    John M Davis
    N Engl J Med 354:518-20. 2006
  2. ncbi Is the superior efficacy of new generation antipsychotics an artifact of LOCF?
    Stefan Leucht
    Klinik für Psychiatrie und Psychotherapie der TU München, Klinikum rechts der Isar, Ismaningerstr 22, 81675 Munchen, Germany
    Schizophr Bull 33:183-91. 2007
  3. ncbi Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effect
    John M Davis
    Department of Psychiatry, University of Illinois at Chicago, 1601 W Taylor Street, Chicago, IL 60612, USA
    Neuropsychopharmacology 33:971-5. 2008
  4. ncbi L-methionine decreases dendritic spine density in mouse frontal cortex
    Patricia Tueting
    Department of Psychiatry, Psychiatric Institute, College of Medicine, University of Illinois at Chicago, USA
    Neuroreport 21:543-8. 2010
  5. ncbi Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder
    Marin Veldic
    Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois, 1601 West Taylor Street, Chicago, IL 60612, United States
    Schizophr Res 91:51-61. 2007
  6. ncbi Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study
    Robert C Smith
    Department of Psychiatry, New York University Medical School, Hewlett, NY 11557, USA
    Schizophr Res 120:204-9. 2010
  7. ncbi Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression
    Ekrem Maloku
    Department of Psychiatry, Psychiatric Institute, University of Illinois, Chicago, IL 60612, USA
    Proc Natl Acad Sci U S A 107:4407-11. 2010
  8. ncbi Absence of tolerance to the anticonvulsant and neuroprotective effects of imidazenil against DFP-induced seizure and neuronal damage
    Bashkim Kadriu
    The Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, 1601 W Taylor St, Chicago, IL 60612, USA
    Neuropharmacology 61:1463-9. 2011
  9. ncbi S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis
    Alessandro Guidotti
    Department of Psychiatry, Psychiatric Institute, University of Illinois, Chicago, Illinois, USA
    Neuroreport 18:57-60. 2007
  10. ncbi Reelin down-regulation in mice and psychosis endophenotypes
    Patricia Tueting
    Psychiatric Institute, University of Illinois at Chicago, 1601 West Taylor Street Chicago, IL 60612, USA
    Neurosci Biobehav Rev 30:1065-77. 2006

Detail Information

Publications61

  1. ncbi The choice of drugs for schizophrenia
    John M Davis
    N Engl J Med 354:518-20. 2006
  2. ncbi Is the superior efficacy of new generation antipsychotics an artifact of LOCF?
    Stefan Leucht
    Klinik für Psychiatrie und Psychotherapie der TU München, Klinikum rechts der Isar, Ismaningerstr 22, 81675 Munchen, Germany
    Schizophr Bull 33:183-91. 2007
    ..Ultimately, strategies to reduce dropout rates are needed...
  3. ncbi Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effect
    John M Davis
    Department of Psychiatry, University of Illinois at Chicago, 1601 W Taylor Street, Chicago, IL 60612, USA
    Neuropsychopharmacology 33:971-5. 2008
    ..We were unable to confirm that the drug's EPS properties or antiparkinsonian management altered actual efficacy...
  4. ncbi L-methionine decreases dendritic spine density in mouse frontal cortex
    Patricia Tueting
    Department of Psychiatry, Psychiatric Institute, College of Medicine, University of Illinois at Chicago, USA
    Neuroreport 21:543-8. 2010
    ....
  5. ncbi Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder
    Marin Veldic
    Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois, 1601 West Taylor Street, Chicago, IL 60612, United States
    Schizophr Res 91:51-61. 2007
    ..This suggests that different epigenetic mechanisms must exist in the pathogenesis underlying SZ and BDP and implies that these disorders might involve two separate entities that are characterized by a well-defined neuropathology...
  6. ncbi Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study
    Robert C Smith
    Department of Psychiatry, New York University Medical School, Hewlett, NY 11557, USA
    Schizophr Res 120:204-9. 2010
    ..We present results of a randomized prospective study of lipid metabolism and metabolic syndrome in chronic schizophrenic patients using both fasting and post-prandial lipid measures...
  7. ncbi Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression
    Ekrem Maloku
    Department of Psychiatry, Psychiatric Institute, University of Illinois, Chicago, IL 60612, USA
    Proc Natl Acad Sci U S A 107:4407-11. 2010
    ..This finding suggests that lack of reelin impairs GABAergic Purkinje neuron expression and/or positioning during cerebellar development...
  8. ncbi Absence of tolerance to the anticonvulsant and neuroprotective effects of imidazenil against DFP-induced seizure and neuronal damage
    Bashkim Kadriu
    The Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, 1601 W Taylor St, Chicago, IL 60612, USA
    Neuropharmacology 61:1463-9. 2011
    ..The present findings indicate that protracted imidazenil treatment does not produce tolerance to its protective action against the neurotoxic effects of OP exposure...
  9. ncbi S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis
    Alessandro Guidotti
    Department of Psychiatry, Psychiatric Institute, University of Illinois, Chicago, Illinois, USA
    Neuroreport 18:57-60. 2007
    ....
  10. ncbi Reelin down-regulation in mice and psychosis endophenotypes
    Patricia Tueting
    Psychiatric Institute, University of Illinois at Chicago, 1601 West Taylor Street Chicago, IL 60612, USA
    Neurosci Biobehav Rev 30:1065-77. 2006
    ..Thus, an animal model that combines genetic heterozygocity with epigenesis holds promise for understanding the role of Reelin down-regulation in psychosis...
  11. ncbi GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon
    Alessandro Guidotti
    Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, 1601 Taylor St, Chicago, IL 60612, USA
    Psychopharmacology (Berl) 180:191-205. 2005
    ....
  12. ncbi Acute imidazenil treatment after the onset of DFP-induced seizure is more effective and longer lasting than midazolam at preventing seizure activity and brain neuropathology
    Bashkim Kadriu
    Department of Psychiatry, The Psychiatric Institute, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    Toxicol Sci 120:136-45. 2011
    ..We report here that IMD is more efficacious and longer lasting than sedating doses of MDZ in protecting rats from DFP-induced ECoG seizures and neuronal damage...
  13. ncbi Anticholinesterase (DFP) toxicity antagonism by chronic donepezil: a potential nerve agent treatment
    David S Janowsky
    Department of Psychiatry, CB 7175, Medical Research Building A, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7175, USA
    Pharmacol Biochem Behav 81:917-22. 2005
    ..Although these phenomena are not the same as lethality, they may be parallel phenomena, and our results may have therapeutic implications for the treatment of nerve agent toxicity...
  14. ncbi Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later
    David S Janowsky
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7175, USA
    J Clin Psychiatry 67:1272-7. 2006
    ..The purpose of this study was to determine if relapse during or after antipsychotic drug withdrawal in mentally retarded adults predicts continuing antipsychotic drug use an average of a decade later...
  15. ncbi Testing a level of response to alcohol-based model of heavy drinking and alcohol problems in 1,905 17-year-olds
    Marc A Schuckit
    Department of Psychiatry, University of California, San Diego, La Jolla, California 92037, USA
    Alcohol Clin Exp Res 35:1897-904. 2011
    ..This study evaluates a full LR-based model of risk in a large sample of adolescents from the United Kingdom...
  16. ncbi Antipsychotic withdrawal-induced relapse predicts future relapses in institutionalized adults with severe intellectual disability
    David S Janowsky
    Department of Psychiatry, CB 7175, Medical Research Building A, University of North Carolina, Chapel Hill, NC 27599 7175, USA
    J Clin Psychopharmacol 28:401-5. 2008
    ..Thus, if relapse occurs after an antipsychotic drug withdrawal attempt, subsequent attempts at withdrawal are also very likely to lead to further relapses...
  17. ncbi Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial
    David S Janowsky
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7175, USA
    Int J Neuropsychopharmacol 8:37-48. 2005
    ..The results suggest that serotonergic antidepressants are useful in the treatment of challenging/maladaptive behaviours in the intellectually disabled...
  18. ncbi Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults
    David S Janowsky
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7175, USA
    J Clin Psychopharmacol 25:19-25. 2005
    ..3 mg/d and relapse occurred at a mean dose of 93.6 mg/d. The mean lowest effective dose of haloperidol or related high potency drugs (expressed as haloperidol equivalents) was 5.9 mg/d, and relapse occurred at a mean dose of 3.8 mg/d...
  19. ncbi Lithium-induced renal insufficiency: a longitudinal study of creatinine increases in intellectually disabled adults
    David S Janowsky
    Department of Psychiatry, University of North Carolina Chapel Hill, Chapel Hill, NC, USA
    J Clin Psychopharmacol 31:769-73. 2011
    ..Lithium has been shown to increase serum creatinine levels in a subgroup of patients. However, lithium-induced increases in serum creatinine have not been well studied with regard to timing, trajectory, or predictability...
  20. ncbi Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study
    Robert C Smith
    Department of Psychiatry, NYU Medical School, Hewlett, NY 11557, USA
    J Clin Psychiatry 70:1501-13. 2009
    ..Randomized prospective studies of metabolic effects during treatment with these drugs may provide results that are more informative...
  21. ncbi Old versus new: weighing the evidence between the first- and second-generation antipsychotics
    John M Davis
    Department of Psychiatry M C 912, University of Illinois at Chicago, University of Maryland Psychiatric Research Center, 1601 W Taylor Street, Chicago, IL, USA
    Eur Psychiatry 20:7-14. 2005
    ..Choice of antipsychotic, in our opinion, is probably the most important decision that the clinician makes for the psychotic patient. This involves the choice of drug, its dose, balancing efficacy, side-effects and cost...
  22. ncbi A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia
    John M Kane
    Department of Psychiatry, Hillside Hospital, Glen Oaks, NY 11004, USA
    Am J Psychiatry 159:554-60. 2002
    ..Maintenance medication is critical in the prevention of psychotic relapse and rehospitalization among patients with schizophrenia. Given potential adverse effects, identification of the minimum effective dose is clinically important...
  23. ncbi Choice of maintenance medication for schizophrenia
    John M Davis
    Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, 60612, USA
    J Clin Psychiatry 64:24-33. 2003
    ....
  24. ncbi A meta-analysis of the efficacy of second-generation antipsychotics
    John M Davis
    Psychiatric Institute, University of Illinois at Chicago, 60612, USA
    Arch Gen Psychiatry 60:553-64. 2003
    ....
  25. ncbi Diagnosis and treatment of depression in patients with mental retardation
    David S Janowsky
    Department of Psychiatry, CB 7175, Medical Research Building A, University of North Carolina, Chapel Hill, NC 27599, USA
    Curr Psychiatry Rep 7:421-8. 2005
    ..This article reviews numerous studies elaborating on the diagnosis, phenomenology, and treatment of depression in mentally retarded individuals...
  26. ncbi Imidazenil: an antagonist of the sedative but not the anticonvulsant action of diazepam
    James Auta
    Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, 1601 West Taylor St, Chicago, IL 60612, USA
    Neuropharmacology 49:425-9. 2005
    ..Thus, we suggest that imidazenil might be more effective than FLU at alleviating the withdrawal syndrome associated with long-term BZ administration...
  27. ncbi The Decrease of n-3 Fatty Acid Energy Percentage in an Equicaloric Diet Fed to B6C3Fe Mice for Three Generations Elicits Obesity
    Ingeborg Hanbauer
    Department of Psychiatry, School of Medicine University of Illinois at Chicago, 1601 W Taylor Street, Chicago, IL 60612, USA
    Cardiovasc Psychiatry Neurol 2009:867041. 2009
    ..Hence, reducing dietary alpha-linolenic acid, from 1.02 energy % to 0.16 energy % combined with raising linoleic acid intake resulted in obesity and had detrimental consequences on organ function...
  28. ncbi Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research
    Robert P McMahon
    Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland Baltimore Medical School, Baltimore, MD, USA
    Schizophr Bull 34:292-301. 2008
    ..Shortening placebo-controlled trials would reduce patient burden and ethical objections to prolonged administration of placebo and reduce potential bias due to high dropout rates in longer clinical trials...
  29. ncbi Methodological factors influencing measurement and processing of plasma reelin in humans
    Giovanni Lugli
    Department of Psychiatry and Psychiatric Institute, University of Illinois at Chicago, MC 912, 1601 W, Taylor Street, Chicago, IL 60612, USA
    BMC Biochem 4:9. 2003
    ..Here we describe the methodological and biological foundation for carrying out and interpreting clinical studies of plasma reelin...
  30. ncbi American College of Neuropsychopharmacology--43rd annual meeting. 12-16 December 2004, San Juan, Puerto Rico
    John M Davis
    Illinois State Psychiatric Institute, Room 309, 1601 West Taylor Street, West Chicago, IL 60612-4397, USA
    IDrugs 8:100-3. 2005
  31. ncbi MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness
    Neil R Smalheiser
    Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL 60612, USA
    Int J Neuropsychopharmacol 14:1315-25. 2011
    ..Thus, miRNAs participate in the alterations of gene expression networks that underlie the normal (NLH) as well as aberrant (LH) response to repeated shocks...
  32. ncbi Commentary on strategies for switching antipsychotics
    John M Davis
    Department of Psychiatry, University of Illinois at Chicago, 1601 West Taylor Street, Chicago, IL 60612, USA
    BMC Med 6:18. 2008
    ..In this issue, Ganguli et al. have carried out a randomized switching study, the data from which indicates the tactics that might be optimal. We put this paper into context, provide a critique and describe indications for switching...
  33. ncbi The performance of elements of a 'level of response to alcohol'-based model of drinking behaviors in 13-year-olds
    Marc A Schuckit
    Department of Psychiatry, University of California, San Diego, CA 92161 2002, USA
    Addiction 103:1786-92. 2008
    ..The goals of this paper are to evaluate whether drinking practices among peers mediates the relationship between a low level of response (LR) to alcohol and a person's heavier drinking and alcohol-related problems in 12-14-year-olds...
  34. ncbi Lithium effect on renal glomerular function in individuals with intellectual disability
    David S Janowsky
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7160, USA
    J Clin Psychopharmacol 29:296-9. 2009
    ..The current study evaluated the effects of chronic administration of lithium on renal functioning in an intellectually disabled population...
  35. ncbi Dose response and dose equivalence of antipsychotics
    John M Davis
    Department of Psychiatry, The Psychiatric Institute, University of Illinois at Chicago, Chicago, IL 60612, USA
    J Clin Psychopharmacol 24:192-208. 2004
    ..3 to 10 mg). While high-dose FGAs are not less effective, we feel it is important not to avoid using high dose to avoid excessive toxicity...
  36. ncbi In psychosis, cortical interneurons overexpress DNA-methyltransferase 1
    Marin Veldic
    Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois, 1601 West Taylor Street, Chicago, IL 60612, USA
    Proc Natl Acad Sci U S A 102:2152-7. 2005
    ..Interestingly, the DNMT1 increase failed to occur when patients with psychosis received a combination of valproate and APS treatment but not APS monotherapy...
  37. ncbi The neuropharmacology of psychosis
    Carol A Tamminga
    Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, NE5 110F, Dallas, TX 75390 9127, USA
    Schizophr Bull 33:937-46. 2007
    ..We discuss the kinds of data necessary to further support the dimensional aspects of psychosis...
  38. ncbi Should we treat depression with drugs or psychological interventions? A reply to Ioannidis
    John M Davis
    Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA
    Philos Ethics Humanit Med 6:8. 2011
    ....
  39. ncbi Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial
    David S Janowsky
    Department of Psychiatry, CB 7175, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7175, USA
    J Clin Psychiatry 64:1258-65. 2003
    ..The effectiveness of olanzapine in treating challenging behaviors in the intellectually disabled and its ability to substitute for conventional antipsychotic drugs were evaluated...
  40. ncbi Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine
    Robert D Gibbons
    Department of Medicine, University of Chicago, Chicago, IL 60637, USA
    Arch Gen Psychiatry 69:572-9. 2012
    ..Some meta-analyses suggest that efficacy of antidepressants for major depression is overstated and limited to severe depression...
  41. ncbi Clinical profile of an atypical antipsychotic: risperidone
    John M Davis
    The Psychiatric Institute, University of Illinois at Chicago, 60612, USA
    Schizophr Bull 28:43-61. 2002
    ..Second, we performed a meta-analysis of 18 controlled risperidone trials: risperidone was consistently more effective than conventional antipsychotics in treating positive and negative symptoms...
  42. ncbi Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: a preliminary study
    David S Janowsky
    Department of Psychiatry, University of North Carolina, CB 7175, Medical Research Building A, Chapel Hill, NC 27599 7175, USA
    Pharmacol Biochem Behav 77:337-43. 2004
    ..Therefore, these preliminary findings are encouraging, but many additional studies are needed to establish the effectiveness of donepezil as a prophylactic agent against irreversible cholinesterase inhibition by DFP...
  43. ncbi Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry
    Marlene P Freeman
    Women s Mental Health Program, Department of Psychiatry, University of Arizona College of Medicine, Tucson 85724 5002, USA
    J Clin Psychiatry 67:1954-67. 2006
    ..To determine if the available data support the use of omega-3 essential fatty acids (EFA) for clinical use in the prevention and/or treatment of psychiatric disorders...
  44. ncbi Switch or stay?
    John M Davis
    Am J Psychiatry 163:2032-3. 2006
  45. ncbi Physical health monitoring of patients with schizophrenia
    Stephen R Marder
    Department of Veterans Affairs Greater Los Angeles Healthcare System, CA, USA
    Am J Psychiatry 161:1334-49. 2004
    ..The authors discuss a consensus panel's recommendations for improving the physical health monitoring of patients with schizophrenia who are treated in outpatient settings...
  46. ncbi The Mount Sinai conference on the pharmacotherapy of schizophrenia
    Stephen R Marder
    VA Desert Pacific Mental Illness Research Education and Clinical Center, West Los Angeles VA Health Care Center, CA 90073, USA
    Schizophr Bull 28:5-16. 2002
    ....
  47. ncbi Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia
    Ira D Glick
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Clin Psychiatry 67:1261-5. 2006
    ..To our knowledge, there have been no published reports of prospective systematic investigations of the efficacy of unrestricted CPM use in nonacute schizophrenia...
  48. ncbi The costs of drugs for schizophrenia
    Robert Freedman
    Am J Psychiatry 163:2029-31. 2006
  49. ncbi All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis
    Charles M Beasley
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
    J Clin Psychopharmacol 27:252-8. 2007
    ..This integrated analysis compared the likelihood of discontinuation from olanzapine treatment versus other antipsychotics among patients with schizophrenia...
  50. ncbi Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs
    Stefan Leucht
    Department of Psychiatry and Psychotherapy, Technische Universitat Munchen, Klinikum rechts der Isar, Ismaningerstrasse 22, 81675 Munich, Germany
    Neuropsychopharmacology 32:1903-10. 2007
    ..We suggest a table presenting responder rates in 25 percent steps covering the whole range up to 100% reduction from baseline, which could be displayed together with recently presented criteria for remission...
  51. ncbi Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial
    Brian Hallahan
    Department of Psychiatry, Beaumont Hospital and The Royal College of Surgeons in Ireland, Ireland
    Br J Psychiatry 190:118-22. 2007
    ..Trials have demonstrated benefits of long-chain omega-3 essential fatty acid (n-3 EFA) supplementation in a variety of psychiatric disorders...
  52. ncbi First- and second-generation antipsychotics: learning from CUtLASS and CATIE
    Rajiv Tandon
    Arch Gen Psychiatry 64:977-8; author reply 979-80. 2007
  53. ncbi Thrombostatin, a bradykinin metabolite, reduces platelet activation in a model of arterial wall injury
    Alejandro R Prieto
    Department of Internal Medicine, Division of Cardiology, Michigan State University, East Lansing, MI 48824, USA
    Cardiovasc Res 53:984-92. 2002
    ..5x (P<0.03) using laser-light scattering and platelet adhesion by 1.8x (P<0.02). CONCLUSION: Thrombostatin or aspirin independently decreases evidence of platelet activation in the canine carotid artery model of BA injury...
  54. ncbi Genetic dissection of fusiform rust and pitch canker disease traits in loblolly pine
    Gogce C Kayihan
    School of Forest Resources and Conservation, University of Florida, PO Box 110410, Gainesville, FL 32611, USA
    Theor Appl Genet 110:948-58. 2005
    ..The disease phenotyping described here is a critical step towards identifying specific loci and alleles associated with fusiform rust and pitch canker resistance...
  55. ncbi Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases
    John M Davis
    Division of Rheumatology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Clinic, Rochester, Minnesota 55905, USA
    Medicine (Baltimore) 84:208-17. 2005
    ..This may represent test bias or false-positive anti-ENA assays or false-negative ANA assays, or may imply immune-related mechanisms not previously described...
  56. ncbi Are there problems with the "time compressed model" of iron overload?
    Lana Kaiser
    J Lab Clin Med 143:130-2; author reply 133-4. 2004
  57. ncbi Has research informed us on the practical drug treatment of schizophrenia?
    John M Davis
    Schizophr Bull 34:403-5. 2008
  58. ncbi Does the gerbil model mimic human iron overload?
    Lana Kaiser
    J Lab Clin Med 141:419-20; author reply 420-2. 2003
  59. ncbi Treating schizophrenia with comorbid depressive or demoralization symptoms
    Ira D Glick
    J Clin Psychiatry 69:501. 2008
  60. ncbi Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica
    Hilal Maradit Kremers
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 57:279-86. 2007
    ..To examine the effect of glucocorticoid use on the risk of various cardiovascular diseases in patients with polymyalgia rheumatica (PMR)...
  61. ncbi Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study
    John M Davis
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Arthritis Rheum 56:820-30. 2007
    ..To determine the relationship between glucocorticoid exposure and cardiovascular (CV) events in patients with rheumatoid arthritis (RA)...